Robert Getzenberg, a former Hopkins and Pitt cancer researcher, has retracted another paper, his seventh.
Here’s the notice for “Highly specific urine-based marker of bladder cancer,” a paper first published in Urology in 2005: Continue reading Oncology researcher Getzenberg notches seventh retraction
Robert Getzenberg, a former researcher at Hopkins and Pitt, has retracted a sixth paper, this one in Cancer Research.
Here’s the notice for “Mechanistic Analysis of the Role of BLCA-4 in Bladder Cancer Pathobiology:” Continue reading Former Hopkins and Pitt cancer researcher notches sixth retraction
A cancer researcher whose work was the subject of a lawsuit has retracted his fifth paper, this one from 2004.
Robert Getzenberg, formerly of the University of Pittsburgh and Johns Hopkins, has had two papers on prostate cancer biomarkers retracted, and two on colon cancer. The newly retracted paper is about a potential bladder cancer biomarker.
Here’s the notice from Clinical Cancer Research: Continue reading A fifth retraction for former Pitt and Hopkins oncology researcher Getzenberg
A group of cancer researchers formerly centered at Johns Hopkins have retracted two more studies. The previous two retracted papers — one of which was the focus of a lawsuit — were about prostate cancer, while the new retractions are of papers about colon cancer.
Here’s the notice for one paper: Continue reading Retractions three and four for Hopkins cancer biomarker group
Robert Getzenberg, the Johns Hopkins prostate cancer researcher who has recently retracted two papers involved in work he was sued over, has left the university, Retraction Watch has learned.
Getzenberg, who directed the Research Laboratories at the Hopkins’ Brady Urological Institute, has been working on an alternative to the prostate-specific antigen (PSA) test. In 2009, he — along with Hopkins and Pitt, his former employer — was sued by a company that funded his work, Science magazine reported at the time. The suits were eventually settled for an undisclosed amount, and Getzenberg and his colleagues have now retracted two papers, one in Urology and one in The Prostate, as we’ve reported. Continue reading Prostate cancer researcher who retracted two studies at center of lawsuit departs Hopkins
Earlier this year, we reported on the case of Robert Getzenberg of Johns Hopkins, who retracted a 2007 paper in Urology that was “at the center of two 2009 lawsuits brought by a company that funded the work.”
Getzenberg has now retracted a related paper, “Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2,” published in The Prostate in 2009 and cited nine times, according to Thomson Scientific’s Web of Knowledge.
The notice in The Prostate goes further than the one in Urology, using the word “falsification:” Continue reading Another retraction for potential prostate cancer test from Hopkins
The authors of a study in Urology that was at the center of two 2009 lawsuits brought by a company that funded the work have retracted the paper.
The idea behind the research — by Robert Getzenberg and colleagues at Johns Hopkins — was to find an alternative to the prostate specific antigen (PSA) test, which many urologists recommend, but which many groups — including the US Preventive Services Task Force — find wanting. The work gave rise to a company, Onconome, Science reported in a 2009 story about the lawsuits: Continue reading Hopkins scientists retract prostate cancer screening study at center of 2009 lawsuits